CAMP
Camp4 Therapeutics Corp
NASDAQ · Healthcare · Biotechnology · US
$3.14
−0.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 23.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -284.34x
- Price / sales
- 46.74x
- Price / cash flow
- -6.89x
Enterprise value
- Enterprise value
- $112.3M
- EV / sales
- 26.63x
- EV / EBITDA
- -1.55x
- EV / EBIT
- -2.14x
- Market cap
- $197.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026